Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides comprehensive training, and offers ongoing patient assistance, including clinical oversight and coordinating supply deliveries directly to patients. In the United States, Fresenius Medical Care also contracts with hospitals to provide vital dialysis interventions for hospitalized individuals suffering from end-stage renal disease (ESRD) and acute kidney failure. Beyond services, it is a prominent developer, manufacturer, and distributor of a broad range of dialysis products. This portfolio encompasses polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers and solutions, concentrates, bloodlines, renal pharmaceuticals, and water treatment systems. Additionally, the company produces non-dialysis medical devices, including acute cardiopulmonary and apheresis products. Its pharmaceutical division focuses on developing, acquiring, and in-licensing specialized renal medications, distributing these essential drugs and supplies to both individual patients' homes and dialysis centers. The company also extends its medical offerings to include a variety of specialized services such as vascular, cardiovascular, and endovascular care, operating ambulatory surgery centers for vascular procedures, and providing physician services in nephrology and cardiology. Products are sold directly to dialysis clinics, hospitals, and specialized treatment centers, complemented by sales through local teams, independent distributors, dealers, and agents. By February 23, 2022, Fresenius Medical Care managed an impressive network of 4,171 outpatient dialysis clinics across roughly 150 countries. Established in 1996, the company maintains its headquarters in Bad Homburg, Germany.
What is Fresenius Medical Care stock price today?▼
The current price of FMS is $23.45 USD — it has increased by +1.87% in the past 24 hours. Watch Fresenius Medical Care stock price performance more closely on the chart.
What is Fresenius Medical Care stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Fresenius Medical Care stocks are traded under the ticker FMS.
Is Fresenius Medical Care stock price growing?▼
FMS stock has risen by +7.62% compared to the previous week, the month change is a +8.56% rise, over the last year Fresenius Medical Care has showed a -18.04% decrease.
When is the next Fresenius Medical Care earnings date?▼
Fresenius Medical Care is going to release the next earnings report on August 04, 2026.
What were Fresenius Medical Care earnings last quarter?▼
FMS earnings for the last quarter are 1.05 USD per share, whereas the estimation was 1.17 USD resulting in a -10.06% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Fresenius Medical Care revenue for the last year?▼
Fresenius Medical Care revenue for the last year amounts to 40.79B USD.
What is Fresenius Medical Care net income for the last year?▼
FMS net income for the last year is 1.14B USD.
Does Fresenius Medical Care pay dividends?▼
Yes, FMS dividends are paid annual. The last dividend per share was 0.87 USD. As of today, Dividend Yield (FWD)% is 3.72%.
How many employees does Fresenius Medical Care have?▼
As of June 15, 2026, the company has 112,035 employees.
In which sector is Fresenius Medical Care located?▼
Fresenius Medical Care operates in the Health & Wellness sector.
When did Fresenius Medical Care complete a stock split?▼
The last stock split for Fresenius Medical Care was on December 04, 2012 with a ratio of 2:1.
Where is Fresenius Medical Care headquartered?▼
Fresenius Medical Care is headquartered in Bad Homburg, United States.